BRANDON TRUMBLE: Open Payments
NPI 1972932853 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 134 payments from 19 companies in 2025. Trend: 2023 $1,836 · 2024 $1,644 · 2025 $2,172
Food & beverage: $2,172
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $341 |
| ABBVIE INC. | 24 | $315 |
| Neurocrine BioSciences, Inc. | 13 | $304 |
| ViiV Healthcare Company | 12 | $231 |
| Otsuka America Pharmaceutical, Inc. | 12 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $159 |
| Collegium Pharmaceutical, Inc. | 10 | $152 |
| Teva Pharmaceuticals USA, Inc. | 16 | $150 |
| Janssen Pharmaceuticals, Inc | 5 | $98 |
| Braeburn Inc. | 2 | $38 |
Products named: COBENFY, INGREZZA, APRETUDE, VRAYLAR, CAPLYTA, AUSTEDO XR, MAVYRET, REXULTI.
Industry payments across MO — which companies pay providers there.
